Nasamon Wanlapakorn

About Nasamon Wanlapakorn

Nasamon Wanlapakorn, With an exceptional h-index of 24 and a recent h-index of 22 (since 2020), a distinguished researcher at Chulalongkorn University, specializes in the field of Clinical Virology, Vaccine Immunology, Pediatric Virology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Immunogenicity and durability against Omicron BA. 1, BA. 2 and BA. 4/5 variants at 3–4 months after a heterologous COVID-19 booster vaccine in healthy adults with a two-doses …

Seroprevalence of measles and varicella in healthcare workers in Chonburi province, Thailand between October 2022 and January 2023

Transplacental transfer of maternal antibodies following immunization with recombinant pertussis vaccines during pregnancy: real-world evidence

Impact of subgroup distribution on seasonality of human respiratory syncytial virus: A global systematic analysis

Human Enterovirus B Is a Significant Cause of Aseptic Meningitis and Sepsis-Like Illness in Young Infants in Thailand

Long-Term Dynamic Changes in Hybrid Immunity over Six Months after Inactivated and Adenoviral Vector Vaccination in Individuals with Previous SARS-CoV-2 Infection

Safety and immunogenicity of a third dose of COVID-19 protein subunit vaccine (CovovaxTM) after homologous and heterologous two-dose regimens

The fourth dose of mRNA COVID-19 vaccine following 12 different three-dose regimens: Safety and immunogenicity to Omicron BA. 4/BA. 5

Nasamon Wanlapakorn Information

University

Position

Faculty of Medicine

Citations(all)

1837

Citations(since 2020)

1671

Cited By

462

hIndex(all)

24

hIndex(since 2020)

22

i10Index(all)

56

i10Index(since 2020)

52

Email

University Profile Page

Google Scholar

Nasamon Wanlapakorn Skills & Research Interests

Clinical Virology

Vaccine Immunology

Pediatric Virology

Top articles of Nasamon Wanlapakorn

Title

Journal

Author(s)

Publication Date

Immunogenicity and durability against Omicron BA. 1, BA. 2 and BA. 4/5 variants at 3–4 months after a heterologous COVID-19 booster vaccine in healthy adults with a two-doses …

Heliyon

Suvichada Assawakosri

Sitthichai Kanokudom

Nungruthai Suntronwong

Jira Chansaenroj

Chompoonut Auphimai

...

2024/1/15

Seroprevalence of measles and varicella in healthcare workers in Chonburi province, Thailand between October 2022 and January 2023

medRxiv

Apirat Katanyutanon

Wichai Thanasopon

Chaninan Sonthichai

Piyada Angsuwatcharakorn

Jira Chansaenroj

...

2024

Transplacental transfer of maternal antibodies following immunization with recombinant pertussis vaccines during pregnancy: real-world evidence

International Journal of Infectious Diseases

Surasith Chaithonwongwatthana

Wassana Wijagkanalan

Nasamon Wanlapakorn

Librada Fortuna

Vilasinee Yuwaree

...

2024/4/11

Impact of subgroup distribution on seasonality of human respiratory syncytial virus: A global systematic analysis

The Journal of Infectious Diseases

Shuyu Deng

Ling Guo

Cheryl Cohen

Adam Meijer

Jocelyn Moyes

...

2024/3/15

Human Enterovirus B Is a Significant Cause of Aseptic Meningitis and Sepsis-Like Illness in Young Infants in Thailand

Cureus

Jira Chansaenroj

Preeyaporn Vichaiwattana

Jiratchaya Puenpa

Thaksaporn Thatsanathorn

Natthinee Sudhinaraset

...

2024/2/26

Long-Term Dynamic Changes in Hybrid Immunity over Six Months after Inactivated and Adenoviral Vector Vaccination in Individuals with Previous SARS-CoV-2 Infection

Vaccines

Nungruthai Suntronwong

Sitthichai Kanokudom

Chompoonut Auphimai

Thanunrat Thongmee

Suvichada Assawakosri

...

2024/2/10

Safety and immunogenicity of a third dose of COVID-19 protein subunit vaccine (CovovaxTM) after homologous and heterologous two-dose regimens

International Journal of Infectious Diseases

Sitthichai Kanokudom

Jira Chansaenroj

Nungruthai Suntronwong

Suvichada Assawakosri

Ritthideach Yorsaeng

...

2023/1/1

The fourth dose of mRNA COVID-19 vaccine following 12 different three-dose regimens: Safety and immunogenicity to Omicron BA. 4/BA. 5

Vaccines

Sitthichai Kanokudom

Jira Chansaenroj

Nungruthai Suntronwong

Suvichada Assawakosri

Ritthideach Yorsaeng

...

2023/3/1

SARS-CoV-2 antibody dynamics after COVID-19 vaccination and infection: A real-world cross-sectional analysis

Vaccines

Ritthideach Yorsaeng

Kamolthip Atsawawaranunt

Nungruthai Suntronwong

Sitthichai Kanokudom

Jira Chansaenroj

...

2023/6/30

Simplified test-to-treat strategy for hepatitis C in Thailand: the phetchabun model

The Journal of Infectious Diseases

Rujipat Wasitthankasem

Nasamon Wanlapakorn

Napaporn Pimsing

Nawarat Posuwan

Yong Poovorawan

2023/9/15

Wastewater monitoring in tourist cities as potential sentinel sites for near real-time dynamics of imported SARS-CoV-2 variants

Science of The Total Environment

Jatuwat Sangsanont

Surapong Rattanakul

Prasert Makkaew

Nopadol Precha

Pratchaya Rukthanapitak

...

2023/2/20

An amino acid substitution in HCV core antigen limits its use as a reliable measure of HCV infection compared with HCV RNA

Plos one

Payuda Hansoongnern

Pornpitra Pratedrat

Pornjarim Nilyanimit

Rujipat Wasitthankasem

Nawarat Posuwan

...

2023/6/29

Neutralizing antibodies against Omicron BA. 5 among children with infection alone, vaccination alone, and hybrid immunity

International Journal of Infectious Diseases

Nungruthai Suntronwong

Sitthichai Kanokudom

Suvichada Assawakosri

Preeyaporn Vichaiwattana

Sirapa Klinfueng

...

2023/9/1

Durability of immune response against omicron BA. 2 and BA. 4/5 and T cell responses after boosting with mRNA and adenoviral vector-based vaccines following heterologous …

Human Vaccines & Immunotherapeutics

Nungruthai Suntronwong

Sitthichai Kanokudom

Thaksaporn Thatsanathorn

Thanunrat Thongmee

Natthinee Sudhinaraset

...

2023/12/15

Safety Following COVID-19 Booster Vaccine with BNT162b2 Compared to mRNA-1273 in Solid Cancer Patients Previously Vaccinated with ChAdOx1 or CoronaVac

Vaccines

Passakorn Wanchaijiraboon

Panot Sainamthip

Nattaya Teeyapun

Sutima Luangdilok

Yong Poovorawan

...

2023/2/3

Immunogenicity of the pentavalent DTwP-HB-Hib vaccine (Shan-5) used in the Thai Expanded Program on Immunization compared to the hexavalent DTaP-HB-Hib-IPV and DTwP-HB-Hib …

Vaccine

Nasamon Wanlapakorn

Napa Pruetarat

Nasiri Sarawanangkoor

Kanchana Phanphanit

Donchida Srimuan

...

2023/6/13

Dynamics of cytokine, SARS-CoV-2-specific IgG, and neutralizing antibody levels in COVID-19 patients treated with convalescent plasma

Diseases

Pornpitra Pratedrat

Duangnapa Intharasongkroh

Jira Chansaenroj

Preeyaporn Vichaiwattana

Donchida Srimuan

...

2023/8/30

Epidemiology and clinical characteristics of severe acute respiratory infections among hospitalized children under 5 years of age in a tertiary care center in Bangkok, Thailand …

Heliyon

Nasamon Wanlapakorn

Ilada Thongpan

Nasiri Sarawanangkoor

Preeyaporn Vichaiwattana

Chompoonut Auphimai

...

2023/11/1

Longitudinal Analysis of Association Between Gut Microbiota and Atopic Dermatitis in Thai Children: A Birth Cohort Study

Journal of Allergy and Clinical Immunology

Onnicha Chaiseksamphan

Pannipa Kittipongpattana

Aisawan Petchlorlian

Wanwipa Vongsangnak

Massalin Nakphaichit

...

2023/2/1

Comparison of the reactogenicity and immunogenicity between two‐dose mRNA COVID‐19 vaccine and inactivated COVID‐19 vaccine followed by an mRNA vaccine in children aged 5− 11 years

Journal of Medical Virology

Nasamon Wanlapakorn

Sitthichai Kanokudom

Harit Phowatthanasathian

Jira Chansaenroj

Nungruthai Suntronwong

...

2023/5

See List of Professors in Nasamon Wanlapakorn University(Chulalongkorn University)